share_log

Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2021

Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2021

本辛加2021年11月8日的最高收視率上調、下調
Benzinga Real-time News ·  2021/11/08 22:04

 

 

Upgrades

升級

  • For Nektar Therapeutics (NASDAQ:NKTR), Benchmark upgraded the previous rating of Hold to Buy. Nektar Therapeutics earned $0.70 in the third quarter, compared to $0.61 in the year-ago quarter. The stock has a 52-week-high of $26.75 and a 52-week-low of $12.35. At the end of the last trading period, Nektar Therapeutics closed at $13.45.
  • Needham upgraded the previous rating for Cognex Corp (NASDAQ:CGNX) from Hold to Buy. Cognex earned $0.40 in the third quarter, compared to $0.47 in the year-ago quarter. The stock has a 52-week-high of $101.82 and a 52-week-low of $69.06. At the end of the last trading period, Cognex closed at $78.96.
  • For Interface Inc (NASDAQ:TILE), Raymond James upgraded the previous rating of Market Perform to Outperform. Interface earned $0.29 in the third quarter, compared to $0.28 in the year-ago quarter. At the moment, the stock has a 52-week-high of $17.11 and a 52-week-low of $6.50. Interface closed at $15.99 at the end of the last trading period.
  • According to Deutsche Bank, the prior rating for Accel Entertainment Inc (NYSE:ACEL) was changed from Hold to Buy. In the third quarter, Accel Entertainment showed an EPS of $0.18, compared to $0.16 from the year-ago quarter. The stock has a 52-week-high of $13.75 and a 52-week-low of $8.82. At the end of the last trading period, Accel Entertainment closed at $13.18.
  • According to Truist Securities, the prior rating for Appian Corp (NASDAQ:APPN) was changed from Hold to Buy. In the third quarter, Appian showed an EPS of $0.22, compared to $0.00 from the year-ago quarter. The stock has a 52-week-high of $260.00 and a 52-week-low of $72.00. At the end of the last trading period, Appian closed at $90.73.
  • For KVH Industries Inc (NASDAQ:KVHI), Raymond James upgraded the previous rating of Outperform to Strong Buy. KVH Industries earned $0.05 in the third quarter, compared to $0.06 in the year-ago quarter. The stock has a 52-week-high of $15.29 and a 52-week-low of $8.52. At the end of the last trading period, KVH Industries closed at $10.49.
  • Morgan Stanley upgraded the previous rating for AvalonBay Communities Inc (NYSE:AVB) from Equal-Weight to Overweight. AvalonBay Communities earned $2.06 in the third quarter, compared to $2.06 in the year-ago quarter. The stock has a 52-week-high of $241.63 and a 52-week-low of $146.95. At the end of the last trading period, AvalonBay Communities closed at $237.84.
  • According to Benchmark, the prior rating for ACM Research Inc (NASDAQ:ACMR) was changed from Hold to Buy. ACM Research earned $0.56 in the third quarter, compared to $0.42 in the year-ago quarter. The current stock performance of ACM Research shows a 52-week-high of $144.81 and a 52-week-low of $60.84. Moreover, at the end of the last trading period, the closing price was at $102.69.
  • According to Jefferies, the prior rating for Fair Isaac Corp (NYSE:FICO) was changed from Hold to Buy. Fair Isaac earned $3.38 in the third quarter, compared to $2.58 in the year-ago quarter. The current stock performance of Fair Isaac shows a 52-week-high of $553.97 and a 52-week-low of $379.41. Moreover, at the end of the last trading period, the closing price was at $380.20.
  • For Tenaris SA (NYSE:TS), JP Morgan upgraded the previous rating of Neutral to Overweight. In the third quarter, Tenaris showed an EPS of $0.56, compared to $0.06 from the year-ago quarter. The stock has a 52-week-high of $24.78 and a 52-week-low of $11.77. At the end of the last trading period, Tenaris closed at $24.71.
  • BTIG upgraded the previous rating for AG Mortgage Investment Trust Inc (NYSE:MITT) from Sell to Neutral. For the third quarter, AG Mortgage Investment had an EPS of $0.96, compared to year-ago quarter EPS of $0.44. At the moment, the stock has a 52-week-high of $13.22 and a 52-week-low of $2.65. AG Mortgage Investment closed at $13.00 at the end of the last trading period.
  • 對於 Nektar 療法 （納斯達克股票代碼：NKTR），Benchmark將之前的持有評級上調至買入。Nektar Therapeutics在第三季度的盈利爲0.70美元，而去年同期爲0.61美元。該股創下52周高點26.75美元，創52周低點12.35美元。在上一個交易期結束時，Nektar Therapeutics收於13.45美元。
  • Needham 上調了之前的評級 康耐視公司 納斯達克股票代碼：CGNX）從 “持有” 改爲 “買入”。康耐視在第三季度的收入爲0.40美元，而去年同期爲0.47美元。該股創下52周高點101.82美元，創52周低點69.06美元。在上一個交易期結束時，康耐視收於78.96美元。
  • 對於 英特飛公司 （納斯達克股票代碼：TILE），雷蒙德·詹姆斯將先前的市場表現評級上調至跑贏大盤。Interface在第三季度的盈利爲0.29美元，而去年同期爲0.28美元。目前，該股創下52周高點17.11美元，創52周低點6.50美元。在上一個交易期結束時，Interface收於15.99美元。
  • 根據德意志銀行的說法，先前的評級爲 Accel 娛樂公司 （紐約證券交易所代碼：ACEL）已從 “持有” 更改爲 “買入”。在第三季度，Accel Entertainment的每股收益爲0.18美元，而去年同期爲0.16美元。該股創下52周高點13.75美元，創52周低點8.82美元。在上一個交易期結束時，Accel Entertainment收於13.18美元。
  • 根據Truist Securities的數據，先前的評級爲 Appian Corp 納斯達克股票代碼：APPN）從 “持有” 改爲 “買入”。在第三季度，Appian的每股收益爲0.22美元，而去年同期爲0.00美元。該股創下52周高點260.00美元，創52周低點72.00美元。在上一個交易期結束時，Appian收於90.73美元。
  • 對於 KVH Industries Inc （納斯達克股票代碼：KVHI），雷蒙德·詹姆斯將先前的跑贏大盤評級上調至強勢買入。KVH Industries在第三季度的盈利爲0.05美元，而去年同期爲0.06美元。該股創下52周高點15.29美元，創52周低點8.52美元。在上一個交易期結束時，KVH Industries收於10.49美元。
  • 摩根士丹利上調了先前的評級 AvalonBay 社區公司 （紐約證券交易所代碼：AVB）從同等重量到增重。AvalonBay社區在第三季度的收入爲2.06美元，而去年同期爲2.06美元。該股創下52周高點241.63美元，創52周低點146.95美元。在上一個交易期結束時，AvalonBay社區收於237.84美元。
  • 根據基準，先前的評級爲 ACM 研究公司 納斯達克股票代碼：ACMR）從 “持有” 改爲 “買入”。ACM Research在第三季度的收入爲0.56美元，而去年同期爲0.42美元。ACM Research目前的股票表現顯示，爲52周高點144.81美元，爲52周低點60.84美元。此外，在上一個交易期結束時，收盤價爲102.69美元。
  • 根據傑富瑞的說法，之前的評級是 費爾·艾薩克公司 （紐約證券交易所代碼：FICO）已從 “持有” 更改爲 “買入”。費爾·艾薩克在第三季度的收入爲3.38美元，而去年同期爲2.58美元。Fair Isaac目前的股票表現爲52周高點553.97美元，爲52周低點379.41美元。此外，在上一個交易期結束時，收盤價爲380.20美元。
  • 對於 Tenaris SA （紐約證券交易所代碼：TS），摩根大通將先前的中性評級上調至增持。在第三季度，泰納里斯的每股收益爲0.56美元，而去年同期爲0.06美元。該股創下52周高點24.78美元，創52周低點11.77美元。在上一個交易期結束時，泰納里斯收於24.71美元。
  • BTIG 上調了之前的評級 AG 抵押貸款投資信託公司 紐約證券交易所代碼：MITT）從賣出到中性。第三季度，AG Mortgage Investment的每股收益爲0.96美元，而去年同期的每股收益爲0.44美元。目前，該股創下52周高點13.22美元，創52周低點2.65美元。AG Mortgage Investment在上一個交易期末收於13.00美元。

See all analyst ratings upgrades.

查看所有分析師評級升級。

 

 

Downgrades

降級

  • For Deciphera Pharmaceuticals Inc (NASDAQ:DCPH), Truist Securities downgraded the previous rating of Buy to Hold. For the third quarter, Deciphera Pharmaceuticals had an EPS of $1.37, compared to year-ago quarter EPS of $1.13. At the moment, the stock has a 52-week-high of $68.40 and a 52-week-low of $8.70. Deciphera Pharmaceuticals closed at $8.82 at the end of the last trading period.
  • For bluebird bio Inc (NASDAQ:BLUE), Goldman Sachs downgraded the previous rating of Neutral to Sell. In the third quarter, bluebird bio showed an EPS of $3.16, compared to $2.94 from the year-ago quarter. The stock has a 52-week-high of $53.68 and a 52-week-low of $12.90. At the end of the last trading period, bluebird bio closed at $13.14.
  • Argus Research downgraded the previous rating for Harsco Corp (NYSE:HSC) from Buy to Hold. For the third quarter, Harsco had an EPS of $0.20, compared to year-ago quarter EPS of $0.08. At the moment, the stock has a 52-week-high of $23.73 and a 52-week-low of $12.65. Harsco closed at $15.43 at the end of the last trading period.
  • Northcoast Research downgraded the previous rating for Shake Shack Inc (NYSE:SHAK) from Buy to Neutral. For the third quarter, Shake Shack had an EPS of $0.05, compared to year-ago quarter EPS of $0.11. The stock has a 52-week-high of $138.38 and a 52-week-low of $68.23. At the end of the last trading period, Shake Shack closed at $90.97.
  • For McAfee Corp (NASDAQ:MCFE), Deutsche Bank downgraded the previous rating of Buy to Hold. Interestingly, in the second quarter, McAfee's EPS was $0.28. The stock has a 52-week-high of $32.83 and a 52-week-low of $14.80. At the end of the last trading period, McAfee closed at $25.46.
  • B of A Securities downgraded the previous rating for Purple Innovation Inc (NASDAQ:PRPL) from Buy to Underperform. In the second quarter, Purple Innovation showed an EPS of $0.05, compared to $0.11 from the year-ago quarter. The current stock performance of Purple Innovation shows a 52-week-high of $41.08 and a 52-week-low of $18.50. Moreover, at the end of the last trading period, the closing price was at $19.50.
  • B of A Securities downgraded the previous rating for Spire Inc (NYSE:SR) from Buy to Neutral. In the third quarter, Spire showed an EPS of $0.06, compared to $0.07 from the year-ago quarter. The current stock performance of Spire shows a 52-week-high of $77.95 and a 52-week-low of $57.11. Moreover, at the end of the last trading period, the closing price was at $63.35.
  • According to Piper Sandler, the prior rating for Itron Inc (NASDAQ:ITRI) was changed from Overweight to Neutral. For the third quarter, Itron had an EPS of $0.21, compared to year-ago quarter EPS of $0.61. At the moment, the stock has a 52-week-high of $122.31 and a 52-week-low of $66.32. Itron closed at $79.12 at the end of the last trading period.
  • Morgan Stanley downgraded the previous rating for UDR Inc (NYSE:UDR) from Overweight to Equal-Weight. In the third quarter, UDR showed an EPS of $0.51, compared to $0.50 from the year-ago quarter. The current stock performance of UDR shows a 52-week-high of $56.45 and a 52-week-low of $33.40. Moreover, at the end of the last trading period, the closing price was at $54.81.
  • According to Benchmark, the prior rating for Emergent BioSolutions Inc (NYSE:EBS) was changed from Buy to Hold. For the third quarter, Emergent BioSolutions had an EPS of $0.36, compared to year-ago quarter EPS of $2.19. The stock has a 52-week-high of $127.20 and a 52-week-low of $29.88. At the end of the last trading period, Emergent BioSolutions closed at $33.11.
  • According to Canaccord Genuity, the prior rating for Deciphera Pharmaceuticals Inc (NASDAQ:DCPH) was changed from Buy to Hold. For the third quarter, Deciphera Pharmaceuticals had an EPS of $1.37, compared to year-ago quarter EPS of $1.13. At the moment, the stock has a 52-week-high of $68.40 and a 52-week-low of $8.70. Deciphera Pharmaceuticals closed at $8.82 at the end of the last trading period.
  • Truist Securities downgraded the previous rating for Krispy Kreme Inc (NASDAQ:DNUT) from Buy to Hold. In the second quarter, Krispy Kreme earned $0.13. The current stock performance of Krispy Kreme shows a 52-week-high of $21.69 and a 52-week-low of $12.63. Moreover, at the end of the last trading period, the closing price was at $14.10.
  • According to JMP Securities, the prior rating for Palomar Holdings Inc (NASDAQ:PLMR) was changed from Market Outperform to Market Perform. In the third quarter, Palomar Hldgs showed an EPS of $0.07, compared to $0.60 from the year-ago quarter. The current stock performance of Palomar Hldgs shows a 52-week-high of $115.40 and a 52-week-low of $61.01. Moreover, at the end of the last trading period, the closing price was at $95.00.
  • For Calithera Biosciences Inc (NASDAQ:CALA), HC Wainwright & Co. downgraded the previous rating of Buy to Neutral. Calithera Biosciences earned $0.19 in the second quarter, compared to $0.29 in the year-ago quarter. The current stock performance of Calithera Biosciences shows a 52-week-high of $6.18 and a 52-week-low of $0.83. Moreover, at the end of the last trading period, the closing price was at $0.86.
  • According to Stifel, the prior rating for Deciphera Pharmaceuticals Inc (NASDAQ:DCPH) was changed from Buy to Hold. Deciphera Pharmaceuticals earned $1.37 in the third quarter, compared to $1.13 in the year-ago quarter. The current stock performance of Deciphera Pharmaceuticals shows a 52-week-high of $68.40 and a 52-week-low of $8.70. Moreover, at the end of the last trading period, the closing price was at $8.82.
  • According to Piper Sandler, the prior rating for Aptiv PLC (NYSE:APTV) was changed from Overweight to Neutral. Aptiv earned $0.38 in the third quarter, compared to $1.13 in the year-ago quarter. At the moment, the stock has a 52-week-high of $180.81 and a 52-week-low of $101.14. Aptiv closed at $175.03 at the end of the last trading period.
  • 對於 Deciphera 製藥公司 （納斯達克股票代碼：DCPH），Truist Securities將先前的買入評級下調至持有。第三季度，Deciphera Pharmicals的每股收益爲1.37美元，而去年同期的每股收益爲1.13美元。目前，該股創下52周高點68.40美元，創52周低點8.70美元。Deciphera Pharmicals在上一個交易期結束時收於8.82美元。
  • 對於 藍鳥生物公司 （納斯達克股票代碼：BLUE），高盛將先前的中性評級下調至賣出。在第三季度，藍鳥生物的每股收益爲3.16美元，而去年同期爲2.94美元。該股創下52周高點53.68美元，創52周低點12.90美元。在上一個交易期結束時，藍鳥生物收於13.14美元。
  • 阿格斯研究下調了先前的評級 哈斯科公司 （紐約證券交易所代碼：HSC）從 “買入” 到 “持有”。第三季度，Harsco的每股收益爲0.20美元，而去年同期的每股收益爲0.08美元。目前，該股創下52周高點23.73美元，創52周低點12.65美元。在上一個交易期結束時，Harsco收於15.43美元。
  • Northcoast Research下調了先前的評級 Shake Shack Inc 紐約證券交易所代碼：SHAK）從買入變爲中性。第三季度，Shake Shack的每股收益爲0.05美元，而去年同期的每股收益爲0.11美元。該股創下52周高點138.38美元，創52周低點68.23美元。在上一個交易期結束時，Shake Shack收於90.97美元。
  • 對於 邁克菲公司 （納斯達克股票代碼：MCFE），德意志銀行將先前的買入評級下調至持有。有趣的是，在第二季度，McAfee的每股收益爲0.28美元。該股創下52周高點32.83美元，創52周低點14.80美元。在上一個交易期結束時，McAfee收於25.46美元。
  • B of A Securities 下調了先前的評級 紫色創新公司 納斯達克股票代碼：PRPL）從 “買入” 到 “跑贏大盤”。在第二季度，Purple Innovation的每股收益爲0.05美元，而去年同期爲0.11美元。Purple Innovation目前的股票表現爲52周高點41.08美元，爲52周低點18.50美元。此外，在上一個交易期結束時，收盤價爲19.50美元。
  • B of A Securities 下調了先前的評級 Spire Inc （紐約證券交易所代碼：SR）從買入到中性。在第三季度，Spire的每股收益爲0.06美元，而去年同期爲0.07美元。Spire目前的股票表現爲52周高點77.95美元，爲52周低點57.11美元。此外，在上一個交易期結束時，收盤價爲63.35美元。
  • 根據派珀·桑德勒的說法，之前的評級是 Itron Inc. 納斯達克股票代碼：ITRI）從 “增持” 改爲 “中性”。第三季度，Itron的每股收益爲0.21美元，而去年同期的每股收益爲0.61美元。目前，該股創下52周高點122.31美元，創52周低點66.32美元。在上一個交易期結束時，Itron收於79.12美元。
  • 摩根士丹利下調了先前的評級 UDR Inc （紐約證券交易所代碼：UDR）從超重到等重。在第三季度，UDR的每股收益爲0.51美元，而去年同期爲0.50美元。UDR目前的股票表現爲52周高點56.45美元，爲52周低點33.40美元。此外，在上一個交易期結束時，收盤價爲54.81美元。
  • 根據基準，先前的評級爲 緊急生物解決方案公司 （紐約證券交易所代碼：EBS）已從 “買入” 更改爲 “持有”。第三季度，Emergent BioSolutions的每股收益爲0.36美元，而去年同期的每股收益爲2.19美元。該股創下52周高點127.20美元，創52周低點29.88美元。在上一個交易期結束時，Emergent BioSolutions收於33.11美元。
  • 根據Canaccord Genuity的數據，之前的評級爲 Deciphera 製藥公司 納斯達克股票代碼：DCPH）從 “買入” 更改爲 “持有”。第三季度，Deciphera Pharmicals的每股收益爲1.37美元，而去年同期的每股收益爲1.13美元。目前，該股創下52周高點68.40美元，創52周低點8.70美元。Deciphera Pharmicals在上一個交易期結束時收於8.82美元。
  • Truist Securities下調了先前的評級 Krispy Kreme Inc （納斯達克股票代碼：DNUT）從 “買入” 到 “持有”。在第二季度，Krispy Kreme的收入爲0.13美元。Krispy Kreme目前的股票表現爲52周高點21.69美元，爲52周低點12.63美元。此外，在上一個交易期結束時，收盤價爲14.10美元。
  • 根據JMP Securities的數據，之前的評級爲 帕洛瑪控股公司 納斯達克股票代碼：PLMR）從市場跑贏大盤改爲市場表現。在第三季度，Palomar Hldgs的每股收益爲0.07美元，而去年同期爲0.60美元。帕洛瑪控股目前的股票表現爲52周高點115.40美元，爲52周低點61.01美元。此外，在上一個交易期結束時，收盤價爲95.00美元。
  • 對於 Calithera 生物科學公司 納斯達克股票代碼：CALA），HC Wainwright & Co. 將先前的買入評級下調至中性。Calithera Biosciences在第二季度的盈利爲0.19美元，而去年同期爲0.29美元。Calithera Biosciences目前的股票表現爲52周高點6.18美元，爲52周低點0.83美元。此外，在上一個交易期結束時，收盤價爲0.86美元。
  • 根據Stifel的說法，之前的評級是 Deciphera 製藥公司 納斯達克股票代碼：DCPH）從 “買入” 更改爲 “持有”。Deciphera Pharmicals在第三季度的盈利爲1.37美元，而去年同期爲1.13美元。Deciphera Pharmicals目前的股票表現爲52周高點68.40美元，爲52周低點8.70美元。此外，在上一個交易期結束時，收盤價爲8.82美元。
  • 根據派珀·桑德勒的說法，之前的評級是 Aptiv PLC （紐約證券交易所代碼：APTV）從 “增持” 改爲 “中性”。Aptiv在第三季度的收入爲0.38美元，而去年同期爲1.13美元。目前，該股創下52周高點180.81美元，創52周低點101.14美元。在上一個交易期結束時，Aptiv收於175.03美元。

See all analyst ratings downgrades.

查看所有分析師評級下調。

 

 

Initiations

發起

  • Maxim Group initiated coverage on Paltalk Inc (NASDAQ:PALT) with a Buy rating. The price target for Paltalk is set to $12.00. For the second quarter, Paltalk had an EPS of $0.12, compared to year-ago quarter EPS of $0.08. At the moment, the stock has a 52-week-high of $15.20 and a 52-week-low of $1.10. Paltalk closed at $4.52 at the end of the last trading period.
  • Jefferies initiated coverage on Walker & Dunlop Inc (NYSE:WD) with a Buy rating. The price target for Walker & Dunlop is set to $190.00. Walker & Dunlop earned $2.21 in the third quarter, compared to $1.66 in the year-ago quarter. The stock has a 52-week-high of $147.87 and a 52-week-low of $65.79. At the end of the last trading period, Walker & Dunlop closed at $145.49.
  • With a Buy rating, Benchmark initiated coverage on dMY Technology Group Inc IV (NYSE:DMYQ). The price target seems to have been set at $17.00 for dMY Technology Group Inc. The stock has a 52-week-high of $10.48 and a 52-week-low of $9.57. At the end of the last trading period, dMY Technology Group Inc closed at $10.23.
  • Wedbush initiated coverage on 2seventy bio Inc (NASDAQ:TSVT) with an Outperform rating. The price target for 2seventy bio is set to $40.00. At the end of the last trading period, 2seventy bio closed at $33.62.
  • With a Buy rating, Truist Securities initiated coverage on GitLab Inc (NASDAQ:GTLB). The price target seems to have been set at $175.00 for GitLab. At the end of the last trading period, GitLab closed at $123.54.
  • With an Overweight rating, Barclays initiated coverage on IHS Holding Ltd (NYSE:IHS). The price target seems to have been set at $24.00 for IHS Holding. IHS Holding earned $1.60 in the second quarter, compared to $1.50 in the year-ago quarter. Moreover, at the end of the last trading period, the closing price was at $16.32.
  • Wolfe Research initiated coverage on AvidXchange Holdings Inc (NASDAQ:AVDX) with an Outperform rating. The price target for AvidXchange Holdings is set to $31.00. At the end of the last trading period, AvidXchange Holdings closed at $23.81.
  • B of A Securities initiated coverage on GitLab Inc (NASDAQ:GTLB) with a Buy rating. The price target for GitLab is set to $140.00. At the end of the last trading period, GitLab closed at $123.54.
  • With a Buy rating, B of A Securities initiated coverage on Latham Group Inc (NASDAQ:SWIM). The price target seems to have been set at $18.00 for Latham Group. Latham Group earned $0.49 in the second quarter. At the moment, the stock has a 52-week-high of $34.73 and a 52-week-low of $12.69. Latham Group closed at $16.05 at the end of the last trading period.
  • Goldman Sachs initiated coverage on IHS Holding Ltd (NYSE:IHS) with a Buy rating. The price target for IHS Holding is set to $29.00. In the second quarter, IHS Holding showed an EPS of $1.60, compared to $1.50 from the year-ago quarter. Moreover, at the end of the last trading period, the closing price was at $16.32.
  • Maxim Group 開始報道 Paltalk Inc 納斯達克股票代碼：PALT）評級爲買入。Paltalk的目標股價定爲12.00美元。第二季度，Paltalk的每股收益爲0.12美元，而去年同期的每股收益爲0.08美元。目前，該股創下52周高點15.20美元，創52周低點1.10美元。Paltalk在上一個交易期結束時收於4.52美元。
  • 傑富瑞開始報道 沃克和鄧祿普公司 （紐約證券交易所代碼：WD）的評級爲買入。Walker & Dunlop的目標股價定爲190.00美元。Walker & Dunlop在第三季度的收入爲2.21美元，而去年同期爲1.66美元。該股創下52周高點147.87美元，創52周低點65.79美元。在上一個交易期結束時，Walker & Dunlop收於145.49美元。
  • Benchmark 的評級爲 “買入”，開始報道 dMy 科技集團有限公司 IV （紐約證券交易所：DMYQ）。dMy Technology Group Inc.的目標股價似乎定爲17.00美元。該股創下52周高點10.48美元，創52周低點9.57美元。在上一個交易期結束時，dMy Technology Group Inc收於10.23美元。
  • Wedbush 開始報道於 2sevent bio Inc （納斯達克股票代碼：TSVT）的評級爲跑贏大盤。2seventy bio的目標價格定爲40.00美元。在上一個交易期結束時，2seventy bio收於33.62美元。
  • Truist Securities的評級爲買入，開始了報道 GitLab Inc （納斯達克：GTLB）。GitLab的目標價格似乎已設定爲175.00美元。在上一個交易期結束時，GitLab收於123.54美元。
  • 巴克萊銀行以 “增持” 評級開始報道 IHS 控股有限公司 （紐約證券交易所：IHS）。IHS Holding的目標股價似乎定爲24.00美元。IHS Holding在第二季度的盈利爲1.60美元，而去年同期爲1.50美元。此外，在上一個交易期結束時，收盤價爲16.32美元。
  • Wolfe Research 開始報道 AvidXchange 控股公司 （納斯達克股票代碼：AVDX）的評級爲 “跑贏大盤”。AvidxChange Holdings的目標股價定爲31.00美元。在上一個交易期結束時，AvidxChange Holdings收於23.81美元。
  • B of A Securities 發起了以下報道 GitLab Inc 納斯達克股票代碼：GTLB）評級爲買入。GitLab的目標價格設定爲140.00美元。在上一個交易期結束時，GitLab收於123.54美元。
  • B of A Securities的評級爲買入，開始承保 萊瑟姆集團公司 （納斯達克：游泳）。瑞生集團的目標股價似乎定爲18.00美元。瑞生集團在第二季度的盈利爲0.49美元。目前，該股創下52周高點34.73美元，創52周低點12.69美元。瑞生集團在上一個交易期結束時收於16.05美元。
  • 高盛開始報道 IHS 控股有限公司 紐約證券交易所代碼：IHS）的評級爲買入。IHS Holding的目標股價定爲29.00美元。在第二季度，IHS Holding的每股收益爲1.60美元，而去年同期爲1.50美元。此外，在上一個交易期結束時，收盤價爲16.32美元。

See all analyst ratings initiations.

查看所有分析師評級的啓動。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論